Figure 3.
Overall survival rates for patients in different N subgroups. According to mixed analysis of the five groups, the 5-year survival rate was 80.3% for N0, 64.6% for N1, 38.9% for N2, 28.1% for N3a and 22.1% for N3b. P<0.001. N, lymph node.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.